Andrew J. Last, Director at Oncocyte Corp (OCX), bought 20,000 shares at $0.87 ($17K) on 2022-08-17, disclosed to the SEC on 2022-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| XON | BUY | 2017-11-15 | $24K | — | Filing → |
| XON | BUY | 2017-08-15 | $40K | — | Filing → |
| AFFX | SELL | 2015-03-26 | $1.4M | — | Filing → |